Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Aarti Pharmalabs Limited ( (IN:AARTIPHARM) ) just unveiled an update.
Aarti Pharmalabs Limited, a company involved in the pharmaceutical industry, has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2025. This certificate, provided by their Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirms the dematerialization status of securities and their listing on stock exchanges. The announcement indicates compliance with regulatory requirements, ensuring transparency and proper record-keeping for stakeholders.
More about Aarti Pharmalabs Limited
Average Trading Volume: 20,499
Technical Sentiment Signal: Buy
Current Market Cap: 75.2B INR
Find detailed analytics on AARTIPHARM stock on TipRanks’ Stock Analysis page.